Texas Oncology Cancer Center

Summary

Texas Oncology Cancer Center is a medical facility located in Austin, Texas. This center is recognized for care of Breast Cancer, Ovarian Cancer, Lung Cancer, Cancer, Pancreatic Cancer and other specialties. Texas Oncology Cancer Center is involved with conducting 143 clinical trials across 159 conditions. There are 11 research doctors associated with this hospital, such as Jason M Melear, Debra Patt, Michael Teneriello, and Vivian Cline, MD.

Top PIs

Clinical Trials running at Texas Oncology Cancer Center

Ovarian Cancer

Breast Cancer

Multiple Myeloma

Glioblastoma

Lung Cancer

Cancer

Bladder Cancer

Non-Small Cell Lung Cancer

Fallopian Tube Cancer

Peritoneal Neoplasm

Mirvetuximab + Bevacizumab

for Ovarian Cancer

GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine + Bevacizumab as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.

Recruiting

2 awards

Phase 3

INCB0123667

for Solid Tumors

This trial is testing a new drug called INCB123667 to see if it can help treat advanced or spreading cancers. It aims to find out how safe and effective the drug is, and how the body processes it. The study focuses on patients whose cancers are advanced or have spread.

Recruiting

1 award

Phase 1

ZN-c3

for Serous Carcinoma

This is a multi-part Phase 2 study to evaluate the efficacy and safety of azenosertib (ZN-c3) in subjects with Platinum-Resistant, High-Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer. Part 2 of the study will be conducted in subjects whose tumors are Cyclin E1 positive as determined by central review using the Sponsor's investigational clinical trial assay.

Recruiting

1 award

Phase 2

1 criteria